Study finds lung transplant patients not given antifungal preventive drugs have higher risk of death

ROCHESTER, Minn. -- Antifungal preventive medications reduce mortality risk by half in the first year following lung transplantation, according to Mayo Clinic research involving 667 patients who received lung transplants from 2005 to 2018. The retrospective study, published in the Annals of the American Thoracic Society, is the largest ever to evaluate the effectiveness of [...]
Source: Mayo Clinic Minnesota News - Category: Hospital Management Source Type: news